Analysis of esophagogastric cancer patients enrolled in National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP)-sponsored phase I trials

被引：5
|
作者：
Bando, Hideaki
Rubinstein, Larry
Harris, Pamela Jo
Yoshino, Takayuki
Doi, Toshihiko
Ohtsu, Atsushi
Welch, Jack
Takebe, Naoko
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[2] Div Canc Treatment & Diag, Bethesda, MD USA
[3] NCI, NIH, Bethesda, MD 20892 USA
[4] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[5] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[6] Canc Therapy Evaluat Program, Invest Drug Branch, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Sense of Urgency: Evaluating the Link between Clinical Trial Development Time and the Accrual Performance of Cancer Therapy Evaluation Program (NCI-CTEP) Sponsored Studies
    Cheng, Steven K.
    Dietrich, Mary S.
    Dilts, David M.
    CLINICAL CANCER RESEARCH, 2010, 16 (22) : 5557 - 5563
  • [32] Profile and outcome of cancer patients enrolled in contemporary phase I trials
    Alouani, Emily
    Gazzah, Anas
    Mercier, Sandrine
    Bahleda, Ratislav
    Hollebecque, Antoine
    Michot, Jean-Marie
    Baldini, Capucine
    Ammari, Samy
    Champiat, Stephane
    Marabelle, Aurelien
    Postel-Vinay, Sophie
    Ribrag, Vincent
    Loriot, Yohann
    Aix, Santiago Ponce
    Mahjoubi, Linda
    EUROPEAN JOURNAL OF CANCER, 2023, 188 : 1 - 7
  • [33] Characterization and outcomes of patients enrolled to multiple phase I cancer trials
    Kuehne, Nathan
    Chen, Lina
    McDonald, Kate
    Wang, Lisa
    Spreafico, Anna
    Hansen, Aaron
    Razak, Albiruni Ryan Abdul
    Bedard, Philippe Lucien
    Siu, Lillian L.
    Shepshelovich, Daniel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (02) : 469 - 472
  • [34] The landscape of patients with metastatic breast cancer enrolled in phase I trials
    Marra
    Criscitiello, C.
    Morganti, S.
    Zagami, P.
    Viale, G.
    Tarantino, P.
    Trapani, D.
    Nicolo, E.
    Repetto, M.
    Ferraro, E.
    D'Amico, P.
    Locatelli, M.
    Esposito, A.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S71
  • [35] Characterization and outcomes of patients enrolled to multiple phase I cancer trials
    Nathan Kuehne
    Lina Chen
    Kate McDonald
    Lisa Wang
    Anna Spreafico
    Aaron Hansen
    Albiruni Ryan Abdul Razak
    Philippe Lucien Bedard
    Lillian L. Siu
    Daniel Shepshelovich
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 469 - 472
  • [36] Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute
    Chihara, Dai
    Huang, Erich P.
    Finnigan, Shanda R.
    Cordes, Lisa M.
    Skorupan, Nebojsa
    Fukuda, Yoko
    Rubinstein, Larry, V
    Ivy, S. Percy
    Doroshow, James H.
    Nastoupil, Loretta J.
    Flowers, Christopher R.
    Takebe, Naoko
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17) : 1949 - +
  • [37] NATIONAL-CANCER-INSTITUTE SPONSORED COOPERATIVE CLINICAL-TRIALS
    FRIEDMAN, MA
    CAIN, DF
    CANCER, 1990, 65 (10) : 2376 - 2382
  • [38] Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials
    Chihara, Dai
    Lin, Ruitao
    Flowers, Christopher R.
    Finnigan, Shanda R.
    Cordes, Lisa M.
    Fukuda, Yoko
    Huang, Erich P.
    Rubinstein, Larry, V
    Nastoupil, Loretta J.
    Ivy, S. Percy
    Doroshow, James H.
    Takebe, Naoko
    LANCET, 2022, 400 (10351): : 512 - 521
  • [39] Cancer patient care in clinical trials sponsored by the National Cancer Institute: What does it cost?
    Brown, ML
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (10) : 818 - 819
  • [40] Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies
    Unger, Joseph M.
    Hershman, Dawn L.
    Osarogiagbon, Raymond U.
    Gothwal, Anirudh
    Anand, Seerat
    Dasari, Arvind
    Overnman, Michael
    Loree, Jonathan M.
    Raghav, Kanwal
    CANCER RESEARCH, 2020, 80 (16)
12345